News
SINGAPORE—China is racing toward economic self-sufficiency by weaning itself off American technology. But it has made a ...
Health-care companies rose as investors bet on anti-obesity products. Omada Health shares jumped after the maker of digital products that help track diet and other diabetes factors made its ...
Purdue University's 50-year plan for Indianapolis campus development includes 16 new buildings including the 15-floor ...
After a first place finish Thursday night in the 50m breaststroke final, Lilly King was back in the pool Friday morning.
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
12h
Investor's Business Daily on MSNThe Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.
In honor of Higher Education Day, celebrate FIU’s earning its latest Carnegie recognition — and meet recent alumni who are ...
The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and ...
In the past, studies in type-2 diabetes patients have linked Ozempic to the condition called non-arteritic anterior ischemic ...
Lilly Chiropractic improved to 4-0 in the Greater City League Thursday night, thanks to an 11-6 win over Imler’s Poultry at ...
We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results